Windstream Enterprise Launches LAN Services with Fortinet Technology for Enhanced Security, Business Intelligence and End-User Experiences
New services deliver seamless network integration that helps improve IT agility, innovation and growth across…
Year: 2023
Accenture Invests in SpiderOak to Elevate Satellite Communications Security in Space
NEW YORK–(BUSINESS WIRE)–Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in SpiderOak,…
Helpless Chatbots Face Certain Death as the Era of LLM-powered AI Begins
Quiq revolutionizes customer experience with next generation AI BOZEMAN, Mont.–(BUSINESS WIRE)–Quiq, the technology company creating…
American Bank & Trust Selects Marstone’s Digital Wealth Management Services to Help Expand and Retain Client Relationships
Marstone’s Wealth Management-as-a-Service offering continues to gain traction, growing American Bank & Trust’s wealth management…
Lucy Scientific Discovery Inc. Accelerates Psilocybin Access and Product Launch through a Strategic Partnership with TheraPsil
VANCOUVER, British Columbia, May 18, 2023 (GLOBE NEWSWIRE) — Lucy Scientific Discovery Inc. (“Lucy” or…
Adverum Biotechnologies Presents Nonclinical Data in Support of Ixo-vec’s Phase 2 Clinical Development at ASGCT 2023 Annual Meeting
REDWOOD CITY, Calif., May 18, 2023 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage…
Adverum Biotechnologies Introduces an Intravitreal Gene Therapy Program for Geographic Atrophy and Presents Data on Its Ocular Gene Therapy Platform
– Geographic atrophy (GA) program introduced with complement Factor I (CFI), a key component of…
BeyondSpring and Leading Cancer Center to Present Poster at 2023 ASCO Annual Meeting
NEW YORK, May 18, 2023 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the…
Zymeworks Announces Departure of Neil Klompas, President and Chief Operating Officer
VANCOUVER, British Columbia, May 18, 2023 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage…
BioSyent Schedules Q1 2023 Earnings Release for May 26, 2023
MISSISSAUGA, Ontario, May 18, 2023 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture:…
Biodexa Pharmaceuticals Enters into Non-binding Letter of Intent for Proposed Acquisition of Varian Biopharmaceuticals
18 May 2023 Biodexa Pharmaceuticals Enters into Non-binding Letter of Intent for Proposed Acquisition of…
inFoods® IBS Test Now Validated for Use with Simple Finger Stick Whole Blood Collection Technology
Gastro Health, a leading gastroenterology group, plans to utilize this simplified blood collection method when…
Mustang Bio Announces Strategic Manufacturing Partnership and Portfolio Updates
uBriGene (Boston) Biosciences to acquire Mustang Bio’s Worcester manufacturing facility for total consideration of up…
Outpace Bio to Present New Data on OutSmart™ IL-2/15, a CAR T Cell-Produced Designed Cytokine with Tumor-Localized Immune Cell Activity, at the 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Seattle, WA, May 18, 2023 (GLOBE NEWSWIRE) — Outpace Bio, a company using protein design…
VYNE Therapeutics to Attend BIO International Convention
BRIDGEWATER, N.J., May 18, 2023 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or…
Just in Time for Summer, SweetWater Brewing Introduces Colorado Orange Citrus Ale, a Refreshing New Beer Crafted Exclusively for the High Country
SweetWater Brewing Introduces New Limited Colorado Orange SweetWater ORANGE is brewed with Centennial hops and…
InspireMD Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
TEL AVIV, Israel and MIAMI, May 18, 2023 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR),…
Motus GI Announces $3.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
FORT LAUDERDALE, Fla., May 18, 2023 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS)…
PDS Biotech Completes Enrollment in Immune Checkpoint Inhibitor Naïve Arm of VERSATILE-002 Phase 2 Clinical Trial in Advanced HPV16 Positive Head and Neck Cancer
Company plans to initiate VERSATILE-003 Phase 3 clinical trial in late 2023 FLORHAM PARK, N.J.,…
Galera Announces FDA Orphan Drug Designation Granted to Rucosopasem for Pancreatic Cancer
Rucosopasem in clinical development to augment the anti-cancer efficacy of stereotactic body radiation therapy MALVERN,…